DE1617940C2 - Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes - Google Patents

Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes

Info

Publication number
DE1617940C2
DE1617940C2 DE1617940A DE1617940A DE1617940C2 DE 1617940 C2 DE1617940 C2 DE 1617940C2 DE 1617940 A DE1617940 A DE 1617940A DE 1617940 A DE1617940 A DE 1617940A DE 1617940 C2 DE1617940 C2 DE 1617940C2
Authority
DE
Germany
Prior art keywords
virus
cats
cell
cat
feline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1617940A
Other languages
German (de)
English (en)
Other versions
DE1617940A1 (de
Inventor
Kevin Joseph O'reilly
John London Prydie
Sidney Edwin Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE1617940A1 publication Critical patent/DE1617940A1/de
Application granted granted Critical
Publication of DE1617940C2 publication Critical patent/DE1617940C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE1617940A 1966-02-18 1967-02-20 Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes Expired DE1617940C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB40225/66A GB1177635A (en) 1966-02-18 1966-02-18 Cell Stains.
GB4022566 1966-09-08

Publications (2)

Publication Number Publication Date
DE1617940A1 DE1617940A1 (de) 1970-09-10
DE1617940C2 true DE1617940C2 (de) 1985-05-30

Family

ID=26241297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1617940A Expired DE1617940C2 (de) 1966-02-18 1967-02-20 Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes

Country Status (13)

Country Link
US (1) US3520972A (US20020095090A1-20020718-M00002.png)
JP (1) JPS5341230B1 (US20020095090A1-20020718-M00002.png)
BE (1) BE694243A (US20020095090A1-20020718-M00002.png)
CH (1) CH504532A (US20020095090A1-20020718-M00002.png)
CY (1) CY614A (US20020095090A1-20020718-M00002.png)
DE (1) DE1617940C2 (US20020095090A1-20020718-M00002.png)
DK (1) DK119472B (US20020095090A1-20020718-M00002.png)
ES (1) ES336810A1 (US20020095090A1-20020718-M00002.png)
FR (1) FR1570435A (US20020095090A1-20020718-M00002.png)
GB (1) GB1177635A (US20020095090A1-20020718-M00002.png)
IL (1) IL27418A (US20020095090A1-20020718-M00002.png)
IT (1) IT983058B (US20020095090A1-20020718-M00002.png)
NL (1) NL6702396A (US20020095090A1-20020718-M00002.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1300391A (en) * 1969-08-22 1972-12-20 Nat Res Dev Cell lines and virus culture
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
ZA796477B (en) * 1978-11-30 1981-07-29 Wellcome Found Feline infectious peritonitis vaccine
HU181993B (en) * 1978-11-30 1983-11-28 Wellcome Found Process for producing weakened stock of virus of peritonitis
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
FR2520378A1 (fr) * 1982-01-28 1983-07-29 Vaillant Defresne Laboratoires Perfectionnements apportes aux procedes de preparations de suspensions de cellules fraiches stabilisees destinees a l'usage pharmaceutique, cosmetique ou alimentaire
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US5112756A (en) * 1986-06-02 1992-05-12 Canadian Patents And Development Limited Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells
US11823378B2 (en) * 2019-12-20 2023-11-21 PAIGE.AI, Inc. Systems and methods for processing electronic images to detect contamination in specimen preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (US20020095090A1-20020718-M00002.png) * 1962-11-27
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3450598A (en) * 1965-08-24 1969-06-17 Flow Lab Method for cell propagation
FR1484638A (fr) * 1965-11-17 1967-06-16 Rhone Poulenc Sa Procédé de culture et d'inactivation d'un nouveau virus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
US3520972A (en) 1970-07-21
DE1617940A1 (de) 1970-09-10
IT983058B (it) 1974-10-31
CY614A (en) 1971-10-05
ES336810A1 (es) 1968-01-01
JPS5341230B1 (US20020095090A1-20020718-M00002.png) 1978-11-01
GB1177635A (en) 1970-01-14
FR1570435A (US20020095090A1-20020718-M00002.png) 1969-06-13
IL27418A (en) 1971-06-23
DK119472B (da) 1971-01-11
BE694243A (US20020095090A1-20020718-M00002.png) 1967-08-17
CH504532A (de) 1971-03-15
NL6702396A (US20020095090A1-20020718-M00002.png) 1967-08-21

Similar Documents

Publication Publication Date Title
DE1617940C2 (de) Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes
DE69637251T2 (de) Kultivierung von Lawsonia intracellularis, Impfstoffe gegen Lawsonia intracellularis und diagnostische Mittel
CH617588A5 (US20020095090A1-20020718-M00002.png)
DE69923470T2 (de) Kombinationsimpfstoff gegen hav und masernvirus und verfahren zu seiner produktion
DE2713371C2 (US20020095090A1-20020718-M00002.png)
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE2828073C2 (de) Verfahren zum Kultivieren von Viren
DE2616407A1 (de) Tollwut-vaccine und verfahren zu ihrer herstellung
DE2553998C2 (de) Mumpsvaccin und Verfahren zu seiner Herstellung
CH429024A (de) Verfahren zur Herstellung eines lebendes, abgeschwächtes Masernvirus enthaltenden Impfstoffes
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE1176317B (de) Verfahren zur Herstellung von fuer Impf-zwecke geeigneten waessrigen Fluessigkeiten mit Tollwut-Virus
DE2415353C2 (US20020095090A1-20020718-M00002.png)
DE841333C (de) Verfahren zur Herstellung von Bakterienpraeparaten von Treponema Pallidum
DE2058645C2 (de) Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs
CH639420A5 (en) Process for the production of an RS virus
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
DE1235505B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
AT231068B (de) Verfahren zur Herstellung von Vaccinzwischenprodukten
AT226363B (de) Verfahren zur Herstellung eines Vaccins gegen infektiösen Hepatitisvirus
DE2805029C2 (de) Impfstoff gegen virale hämorrhagische Sepsis von Forellen sowie Verfahren zu dessen Herstellung
EP0158285B1 (de) Verfahren zur Gewinnung von Zellkulturen
AT246922B (de) Verfahren zur Herstellung einer Vakzine aus lebenden, abgeschwächten Masernviren
DE2517550C3 (de) Verfahren zum Herstellen eines Lebend-Impfstoffs zum Immunisieren von fleischfressenden Tieren gegen Staupe
DE3779444T2 (de) Impfstoff gegen herpes simplex.

Legal Events

Date Code Title Description
AG Has addition no.

Ref country code: DE

Ref document number: 1950774

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition